(-)-anisomycin increases expression ISO EVI2A (Homo sapiens) 6480464 Anisomycin results in increased expression of EVI2A mRNA CTD PMID:24247028 1,2-dichloroethane decreases expression EXP 6480464 ethylene dichloride results in decreased expression of EVI2A mRNA CTD PMID:28960355 1-nitropyrene increases expression ISO EVI2A (Homo sapiens) 6480464 1-nitropyrene results in increased expression of EVI2A mRNA CTD PMID:19041380 17alpha-ethynylestradiol multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EVI2A mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO EVI2A (Homo sapiens) 6480464 Estradiol affects the expression of EVI2A mRNA CTD PMID:14699072 17beta-estradiol multiple interactions ISO Evi2a (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EVI2A mRNA CTD PMID:32741896 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of EVI2A mRNA CTD PMID:19484750 17beta-estradiol multiple interactions ISO EVI2A (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of EVI2A mRNA CTD PMID:20660070 17beta-estradiol 3-benzoate multiple interactions ISO Evi2a (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EVI2A mRNA CTD PMID:32741896 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO EVI2A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of EVI2A mRNA CTD PMID:17101203 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Evi2a (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of EVI2A mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Evi2a (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of EVI2A mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EVI2A mRNA CTD PMID:17942748 2-hydroxypropanoic acid increases expression ISO EVI2A (Homo sapiens) 6480464 Lactic Acid results in increased expression of EVI2A mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A increases expression EXP 6480464 tetrabromobisphenol A results in increased expression of EVI2A mRNA CTD PMID:25172293 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO EVI2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EVI2A mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of EVI2A mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Propylthiouracil results in decreased expression of EVI2A mRNA CTD PMID:24780913 and PMID:25825206 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:32553695 acetamide increases expression ISO Evi2a (Rattus norvegicus) 6480464 acetamide results in increased expression of EVI2A mRNA CTD PMID:31881176 antirheumatic drug decreases expression ISO EVI2A (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of EVI2A mRNA CTD PMID:24449571 aristolochic acid A increases expression ISO EVI2A (Homo sapiens) 6480464 aristolochic acid I results in increased expression of EVI2A mRNA CTD PMID:33212167 arsenous acid increases expression ISO EVI2A (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of EVI2A mRNA CTD PMID:24356939 atrazine decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Atrazine results in decreased expression of EVI2A mRNA CTD PMID:36841081 benzene increases expression ISO EVI2A (Homo sapiens) 6480464 Benzene results in increased expression of EVI2A mRNA CTD PMID:20359517 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of EVI2A mRNA CTD PMID:21569818 benzo[a]pyrene increases methylation ISO EVI2A (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of EVI2A 5' UTR CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene metabolite results in increased expression of EVI2A mRNA CTD PMID:32553695 benzo[a]pyrene decreases expression ISO EVI2A (Homo sapiens) 6480464 Benzo(a)pyrene metabolite results in decreased expression of EVI2A mRNA CTD PMID:24356939 bisphenol A affects expression ISO Evi2a (Rattus norvegicus) 6480464 bisphenol A affects the expression of EVI2A mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EVI2A mRNA CTD PMID:32156529 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EVI2A mRNA CTD PMID:35479511 bisphenol A decreases expression ISO Evi2a (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of EVI2A mRNA CTD PMID:34947998 bisphenol A multiple interactions ISO EVI2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EVI2A mRNA CTD PMID:28628672 butanal increases expression ISO EVI2A (Homo sapiens) 6480464 butyraldehyde results in increased expression of EVI2A mRNA CTD PMID:26079696 calcitriol decreases expression ISO EVI2A (Homo sapiens) 6480464 Calcitriol results in decreased expression of EVI2A mRNA CTD PMID:26485663 carbon nanotube increases expression EXP 6480464 Nanotubes more ... CTD PMID:25554681 chloroprene decreases expression EXP 6480464 Chloroprene results in decreased expression of EVI2A mRNA CTD PMID:23125180 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVI2A mRNA CTD PMID:20938992 clofibrate multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of EVI2A mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EVI2A mRNA] CTD PMID:17585979 copper atom decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Copper results in decreased expression of EVI2A mRNA CTD PMID:30556269 copper(0) decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Copper results in decreased expression of EVI2A mRNA CTD PMID:30556269 Cuprizon decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Cuprizone results in decreased expression of EVI2A mRNA CTD PMID:26577399 and PMID:27523638 cyclophosphamide decreases expression ISO EVI2A (Homo sapiens) 6480464 Cyclophosphamide metabolite results in decreased expression of EVI2A mRNA CTD PMID:24356939 deoxynivalenol increases expression ISO EVI2A (Homo sapiens) 6480464 deoxynivalenol results in increased expression of EVI2A mRNA CTD PMID:24247028 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of EVI2A mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO EVI2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EVI2A mRNA CTD PMID:28628672 diarsenic trioxide increases expression ISO EVI2A (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of EVI2A mRNA CTD PMID:24356939 dibutyl phthalate increases expression ISO Evi2a (Rattus norvegicus) 6480464 Dibutyl Phthalate results in increased expression of EVI2A mRNA CTD PMID:21266533 dichloromethane increases expression ISO EVI2A (Homo sapiens) 6480464 Methylene Chloride results in increased expression of EVI2A mRNA CTD PMID:20359517 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of EVI2A mRNA CTD PMID:21041162 ethylbenzene increases expression ISO EVI2A (Homo sapiens) 6480464 ethylbenzene results in increased expression of EVI2A mRNA CTD PMID:20359517 fluoxetine increases expression ISO EVI2A (Homo sapiens) 6480464 Fluoxetine results in increased expression of EVI2A mRNA CTD PMID:24356939 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVI2A mRNA CTD PMID:20938992 gamma-hexachlorocyclohexane increases expression ISO EVI2A (Homo sapiens) 6480464 Hexachlorocyclohexane results in increased expression of EVI2A mRNA CTD PMID:24356939 indometacin multiple interactions ISO EVI2A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of EVI2A mRNA CTD PMID:28628672 ionomycin increases expression ISO EVI2A (Homo sapiens) 6480464 Ionomycin results in increased expression of EVI2A mRNA CTD PMID:24247028 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVI2A mRNA CTD PMID:20938992 lipopolysaccharide multiple interactions ISO EVI2A (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EVI2A mRNA CTD PMID:35811015 lipopolysaccharide decreases expression ISO EVI2A (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of EVI2A mRNA CTD PMID:35811015 methyl methanesulfonate decreases expression ISO EVI2A (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of EVI2A mRNA CTD PMID:23649840 nickel atom increases expression ISO EVI2A (Homo sapiens) 6480464 Nickel results in increased expression of EVI2A mRNA CTD PMID:24768652 and PMID:25583101 o-xylene increases expression ISO EVI2A (Homo sapiens) 6480464 2-xylene results in increased expression of EVI2A mRNA CTD PMID:20359517 ochratoxin A decreases expression ISO EVI2A (Homo sapiens) 6480464 ochratoxin A metabolite results in decreased expression of EVI2A mRNA and ochratoxin A results in decreased expression of EVI2A mRNA CTD PMID:24356939 oxaliplatin multiple interactions ISO Evi2a (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of EVI2A mRNA CTD PMID:25729387 ozone multiple interactions ISO EVI2A (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of EVI2A mRNA CTD PMID:35430440 paracetamol multiple interactions EXP 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of EVI2A mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of EVI2A mRNA] CTD PMID:17585979 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of EVI2A mRNA CTD PMID:17562736 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of EVI2A mRNA CTD PMID:20813756 pravastatin decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Pravastatin results in decreased expression of EVI2A mRNA CTD PMID:27225895 pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of EVI2A mRNA CTD PMID:27225895 progesterone increases expression ISO EVI2A (Homo sapiens) 6480464 Progesterone results in increased expression of EVI2A mRNA CTD PMID:18070364 progesterone multiple interactions ISO EVI2A (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in decreased expression of EVI2A mRNA CTD PMID:20660070 rac-lactic acid increases expression ISO EVI2A (Homo sapiens) 6480464 Lactic Acid results in increased expression of EVI2A mRNA CTD PMID:30851411 raloxifene multiple interactions ISO EVI2A (Homo sapiens) 6480464 [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of EVI2A mRNA CTD PMID:19059307 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO EVI2A (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of EVI2A mRNA CTD PMID:35811015 silicon dioxide increases expression ISO EVI2A (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of EVI2A mRNA CTD PMID:25895662 sirolimus increases expression ISO EVI2A (Homo sapiens) 6480464 Sirolimus results in increased expression of EVI2A mRNA CTD PMID:24356939 sotorasib multiple interactions ISO EVI2A (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EVI2A mRNA CTD PMID:36139627 tamoxifen multiple interactions ISO EVI2A (Homo sapiens) 6480464 [Tamoxifen co-treated with ESR2 protein] results in decreased expression of EVI2A mRNA CTD PMID:19059307 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of EVI2A mRNA CTD PMID:20937368 temozolomide decreases expression ISO EVI2A (Homo sapiens) 6480464 Temozolomide results in decreased expression of EVI2A mRNA CTD PMID:31758290 testosterone multiple interactions ISO Evi2a (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of EVI2A mRNA CTD PMID:32741896 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of EVI2A mRNA CTD PMID:27339419 and PMID:31919559 thapsigargin increases expression ISO EVI2A (Homo sapiens) 6480464 Thapsigargin results in increased expression of EVI2A mRNA CTD PMID:24247028 thioacetamide increases expression ISO Evi2a (Rattus norvegicus) 6480464 Thioacetamide results in increased expression of EVI2A mRNA CTD PMID:34492290 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of EVI2A mRNA CTD PMID:23557971 and PMID:27760801 titanium dioxide decreases expression EXP 6480464 titanium dioxide results in decreased expression of EVI2A mRNA CTD PMID:29264374 toluene increases expression ISO EVI2A (Homo sapiens) 6480464 Toluene results in increased expression of EVI2A mRNA CTD PMID:20359517 toluene decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Toluene results in decreased expression of EVI2A mRNA CTD PMID:22166486 toluene increases expression ISO Evi2a (Rattus norvegicus) 6480464 Toluene results in increased expression of EVI2A mRNA CTD PMID:22166486 topotecan multiple interactions ISO Evi2a (Rattus norvegicus) 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of EVI2A mRNA CTD PMID:25729387 trametinib multiple interactions ISO EVI2A (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EVI2A mRNA CTD PMID:36139627 Tributyltin oxide increases expression ISO EVI2A (Homo sapiens) 6480464 bis(tri-n-butyltin)oxide results in increased expression of EVI2A mRNA CTD PMID:24247028 trichloroethene increases expression ISO EVI2A (Homo sapiens) 6480464 Trichloroethylene results in increased expression of EVI2A mRNA CTD PMID:20359517 trichloroethene decreases expression ISO Evi2a (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of EVI2A mRNA CTD PMID:33387578 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of EVI2A mRNA CTD PMID:35537566 valproic acid decreases methylation ISO EVI2A (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of EVI2A gene CTD PMID:29154799 zaragozic acid A decreases expression EXP 6480464 squalestatin 1 results in decreased expression of EVI2A mRNA CTD PMID:27225895 zaragozic acid A decreases expression ISO Evi2a (Rattus norvegicus) 6480464 squalestatin 1 results in decreased expression of EVI2A mRNA CTD PMID:27225895